comorbidities for glp 1 Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? GLP-1 patients aren't approaching aesthetics

Go too slowly, or plateau at the wrong dose, and you may stop seeing results without knowing why

We provide these clinician-guided programs through in-person appointments at our physical clinics as well as secure virtual telehealth visits for residents throughout Oregon, Washington, and California

The role of probiotics and prebiotics in modulating of the gut-brain axis

"State of GLP-1 Medication Coverage for Weight Loss: Employer Survey Results." June 2025

The adoption of these beverages over traditional options is driven mainly by the need for nutrient-dense solutions that align with the dietary restrictions necessitated by GLP-1 drugs